Cancers, Vol. 13, Pages 5229: Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views
Conclusions: In RCC patients, the PI3K/Akt signaling is still the most effective targetable pathway. Targeting other metabolic pathways such as c-Met, GSH, and HDAC appears to be a promising approach and deserve further insights.
Source: Cancers - Category: Cancer & Oncology Authors: Gaetano Aurilio Matteo Santoni Francesco Massari Alessia Cimadamore Alessandro Rizzo Veronica Mollica Elena Verri Nicola Battelli Rodolfo Montironi Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Kidney Cancer | Renal Cell Carcinoma | Websites